Product Description

Borviz T 2mg Injection consists of the active substance Bortezomib. It is a chemotherapy medication indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common type of cancer that affects the lymph nodes.

This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. 

How to use

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses

Treatment of Multiple myoloma
Treatment of Mantle cell lymphoma

Side Effects

Serious:

• Muscle cramps
• Confusion, visual disturbances, seizures and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High BP
• Fainting and tiredness
• Cough and chest tightness

Common:

• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting and diarrhea
• Mouth ulcers
• Constipation
• Muscle and bone pain
• Hair loss
• Fever
• Reduction in blood cell count
• Reduced kidney function

Storage

Store below 30℃